William Markland

2.9k total citations · 1 hit paper
31 papers, 2.0k citations indexed

About

William Markland is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William Markland has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William Markland's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Bacteriophages and microbial interactions (9 papers) and Polyomavirus and related diseases (7 papers). William Markland is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Bacteriophages and microbial interactions (9 papers) and Polyomavirus and related diseases (7 papers). William Markland collaborates with scholars based in United States and United Kingdom. William Markland's co-authors include Robert C. Ladner, Alan E. Smith, Arthur C. Ley, Bruce Roberts, Rachel B. Kent, Ted Fox, Paul R. Caron, Thomas McQuaid, Jugnu Jain and Ann D. Kwong and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

William Markland

31 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide

1996 554 citations Kurt Morgenstern, Chao Lin et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Markland United States	20	1.1k	586	509	441	309	31	2.0k
Kurt Morgenstern United States	13	849 0.8×	240 0.4×	740 1.5×	515 1.2×	117 0.4×	19	1.8k
Cécile Voisset France	27	1.2k 1.1×	653 1.1×	1.4k 2.8×	1.3k 3.0×	224 0.7×	57	3.3k
Seng‐Lai Tan United States	24	800 0.8×	255 0.4×	918 1.8×	688 1.6×	231 0.7×	36	2.4k
Paolo Monaci Italy	28	1.9k 1.8×	929 1.6×	162 0.3×	203 0.5×	315 1.0×	53	2.8k
Stanley M. Tahara United States	30	2.5k 2.3×	104 0.2×	220 0.4×	268 0.6×	197 0.6×	63	3.3k
S Kawai Japan	27	1.5k 1.4×	107 0.2×	519 1.0×	800 1.8×	230 0.7×	55	2.9k
Joseph P. Davide United States	22	1.3k 1.2×	163 0.3×	163 0.3×	205 0.5×	461 1.5×	37	2.1k
Petra Neddermann Italy	27	1.8k 1.7×	174 0.3×	1.0k 2.0×	820 1.9×	483 1.6×	36	3.2k
Claus H. Schröder Germany	25	595 0.6×	90 0.2×	909 1.8×	1.5k 3.5×	190 0.6×	57	2.1k
Lars Östberg Sweden	27	843 0.8×	520 0.9×	189 0.4×	423 1.0×	126 0.4×	47	1.9k

Countries citing papers authored by William Markland

Since Specialization

Citations

This map shows the geographic impact of William Markland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Markland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Markland more than expected).

Fields of papers citing papers by William Markland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Markland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Markland. The network helps show where William Markland may publish in the future.

Co-authorship network of co-authors of William Markland

This figure shows the co-authorship network connecting the top 25 collaborators of William Markland. A scholar is included among the top collaborators of William Markland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Markland. William Markland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hillier, Shawn, David Newsome, Daigo Takemoto, et al.. (2016). Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy. Annals of Oncology. 27. vi122–vi122. 4 indexed citations

Jepson, Scott, Bryan W. Vought, Christian H. Gross, et al.. (2012). LINGO-1, a Transmembrane Signaling Protein, Inhibits Oligodendrocyte Differentiation and Myelination through Intercellular Self-interactions. Journal of Biological Chemistry. 287(26). 22184–22195. 86 indexed citations

Farmer, Luc J., Guy W. Bemis, John E. Cochran, et al.. (2008). Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK). Bioorganic & Medicinal Chemistry Letters. 18(23). 6231–6235. 25 indexed citations

Markland, William, et al.. (2000). Structural and Kinetic Analyses of the Protease from an Amprenavir-Resistant Human Immunodeficiency Virus Type 1 Mutant Rendered Resistant to Saquinavir and Resensitized to Amprenavir. Journal of Virology. 74(16). 7636–7641. 14 indexed citations

Xie, Xiaoling, Yong Gu, Ted Fox, et al.. (1998). Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure. 6(8). 983–991. 169 indexed citations

Markland, William, Margaret Fitzgibbon, Ted Fox, et al.. (1997). Purification and characterization of the NS3 serine protease domain of hepatitis C virus expressed in Saccharomyces cerevisiae.. Journal of General Virology. 78(1). 39–43. 22 indexed citations

Markland, William, Bruce Roberts, & Robert C. Ladner. (1996). [2] Selection for protease inhibitors using bacteriophage display. Methods in enzymology on CD-ROM/Methods in enzymology. 267. 28–51. 12 indexed citations

Roberts, Bruce, William Markland, & Robert C. Ladner. (1996). [4] Affinity maturation of proteins displayed on surface of M13 bacteriophage as major coat protein fusions. Methods in enzymology on CD-ROM/Methods in enzymology. 267. 68–82. 6 indexed citations

Morgenstern, Kurt, Chao Lin, Ted Fox, et al.. (1996). Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide. Cell. 87(2). 343–355. 554 indexed citations breakdown →

10.

Ley, Arthur C., William Markland, & Robert C. Ladner. (1996). Obtaining a family of high-affinity, high-specificity protein inhibitors of plasmin and plasma kallikrein. Molecular Diversity. 2(1-2). 119–124. 18 indexed citations

11.

Roberts, Bruce, et al.. (1992). Protease inhibitor display M13 phage: selection of high-affinity neutrophil elastase inhibitors. Gene. 121(1). 9–15. 39 indexed citations

12.

Roberts, Bruce, William Markland, Arthur C. Ley, et al.. (1992). Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.. Proceedings of the National Academy of Sciences. 89(6). 2429–2433. 155 indexed citations

13.

Markland, William, et al.. (1989). Structure–function analysis of tissue-type plasminogen activator by linker-insertion, point and deletion mutagenesis. Protein Engineering Design and Selection. 3(2). 117–125. 7 indexed citations

14.

Markland, William, et al.. (1989). Tissue-type plasminogen activator variants with domain duplications and rearrangements. Protein Engineering Design and Selection. 3(2). 111–116. 5 indexed citations

15.

Markland, William, Alan E. Smith, & Bruce Roberts. (1987). Signal-dependent translocation of simian virus 40 large-T antigen into rat liver nuclei in a cell-free system.. Molecular and Cellular Biology. 7(12). 4255–4265. 43 indexed citations

16.

Markland, William & Alan E. Smith. (1987). Mutants of polyomavirus middle-T antigen. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 907(3). 299–321. 43 indexed citations

17.

Markland, William & Alan E. Smith. (1987). Mapping of the amino-terminal half of polyomavirus middle-T antigen indicates that this region is the binding domain for pp60c-src. Journal of Virology. 61(2). 285–292. 19 indexed citations

18.

Markland, William, Ben A. Oostra, Robert F. Harvey, et al.. (1986). Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. Journal of Virology. 59(2). 384–391. 31 indexed citations

19.

Cheng, Shuk Han, William Markland, Alexander F. Markham, & Alan E. Smith. (1986). Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.. The EMBO Journal. 5(2). 325–334. 40 indexed citations

20.

Markland, William, et al.. (1982). An improved technique for the culture of jerusalem artichoke (Helianthus tuberosus L.) explants for use in the study of xylem differentiation. Plant Cell Reports. 1(5). 229–31. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact